VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research and Development Corp. (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced the formation of its inaugural scientific advisory board (SAB), comprised of internationally renowned scientific and clinical leaders from Canada, the United States, and Europe.

Read more here.